{"id":528,"date":"2019-04-22T09:00:00","date_gmt":"2019-04-22T09:00:00","guid":{"rendered":"https:\/\/isosolution-v2.staging.xiyx.ai\/news\/preclinical-efficacy-of-hk2-targeted-177luhu11b6-for-prostate-cancer-theranostics\/"},"modified":"2019-04-22T09:00:00","modified_gmt":"2019-04-22T09:00:00","slug":"preclinical-efficacy-of-hk2-targeted-177luhu11b6-for-prostate-cancer-theranostics","status":"publish","type":"iso_news","link":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/news\/preclinical-efficacy-of-hk2-targeted-177luhu11b6-for-prostate-cancer-theranostics\/","title":{"rendered":"Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics"},"content":{"rendered":"<p>Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the form of increased androgen receptor (AR) expression. Targeting proteins that are expressed as a down-stream effect of AR activity is a promising rationale for management of this disease.  <a href=\"https:\/\/isosolutions.com\/preclinical-efficacy-of-hk2\/\"><span aria-label=\"Continue reading Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics\">(more&hellip;)<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated\u2026<\/p>","protected":false},"featured_media":556,"template":"","iso_news_section":[43],"class_list":["post-528","iso_news","type-iso_news","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news\/528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news"}],"about":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/types\/iso_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/media\/556"}],"wp:attachment":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/media?parent=528"}],"wp:term":[{"taxonomy":"iso_news_section","embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news_section?post=528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}